@ARTICLE{
author={Bergh Florian Then,Singer BA,Drulovic Jelena S,Bidollari I,Chen Hailu,Englishby R,Hanna Jerome,Kandinov Boris,Lopez-Bresnahan Maria,Leigh-Pemberton Richard,Miller Catherine,Mokliatchouk O,Shafer SJ},
year={2019},
title={Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={25},
number={},
pages={861-862},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Arnold Douglas L,LaGanke Christopher,Obradovic Dragana V,Gudesblatt Mark,Yang Lili,Miller Catherine,Leigh-Pemberton Richard,Lopez-Bresnahan Maria,Kandinov Boris,Wolinsky Jerry S},
year={2019},
title={Diroximel Fumarate (DRF) in Patients With Relapsing-Remitting Multiple Sclerosis: Interim Efficacy and Safety Results From the Phase 3 EVOLVE-MS-1 Study},
journal={NEUROLOGY},
volume={92},
number={15},
pages={-},
document_type={Meeting Abstract},
}